Royal Society

Absci Appoints Professor Sir Mene Pangalos to its Board of Directors

Retrieved on: 
水曜日, 1月 10, 2024
Neuroscience, Royal Society, Patient, Almirall, Medicine, Science, Francis Crick Institute, University, Executive, Drug discovery, Royal, Drug development, Therapy, Translation, AstraZeneca, Biopharmaceutical

In addition to joining Absci’s Board, Sir Pangalos will co-chair Absci’s Scientific Advisory Board.

Key Points: 
  • In addition to joining Absci’s Board, Sir Pangalos will co-chair Absci’s Scientific Advisory Board.
  • VANCOUVER, Wash., Jan. 10, 2024 (GLOBE NEWSWIRE) -- Absci (Nasdaq: ABSI), a generative AI drug creation company, today announced the appointment of seasoned R&D executive Professor Sir Menelas “Mene” Pangalos to its Board of Directors and as co-chair of Absci’s Scientific Advisory Board.
  • Sir Pangalos was the Executive Vice President of BioPharmaceuticals R&D at AstraZeneca.
  • In his dual role, Sir Pangalos will also co-chair Absci’s Scientific Advisory Board.

Professor Andrew L. Hopkins appointed Commander of the Order of the British Empire (CBE)

Retrieved on: 
火曜日, 1月 2, 2024
Health, Technology, Health Technology, Clinical Trials, Artificial Intelligence, Pharmaceutical, Biotechnology, Pfizer, CBE, Medicine, TIME, Commander, Majesty, Informatics, Royal, University, Machine learning, Patient, Biophysics, Royal Society, Algorithm, Pharmaceutical industry

Professor Andrew Hopkins FRS FMedSci, founder and Chief Executive of Exscientia plc (Nasdaq: EXAI), has been appointed Commander of the Order of the British Empire (CBE) for services to Science and Innovation by His Majesty King Charles III.

Key Points: 
  • Professor Andrew Hopkins FRS FMedSci, founder and Chief Executive of Exscientia plc (Nasdaq: EXAI), has been appointed Commander of the Order of the British Empire (CBE) for services to Science and Innovation by His Majesty King Charles III.
  • The appointment reflects Andrew’s life-long passion for harnessing the power of innovative technologies to discover and develop high-quality medicines to benefit patients.
  • This recognition follows multiple previous awards and prestigious honours recently received by both Andrew and Exscientia, the AI-driven precision medicine company he leads.
  • As the company’s CEO, Andrew led the group who discovered the first AI-designed drugs to enter human clinical trials.

Madison Metals Announces Physical Uranium Inventory Strategy and Technical Report Update Progress

Retrieved on: 
木曜日, 11月 30, 2023
Geological Society of London, RWA, Exclusive, Uranium, Metallurgy, Royal Society, Royal, Uranium mining

In support of the token redemption protocol, Madison may execute uranium spot market purchases; build an in-house uranium inventory; purchase futures contracts; and/or purchase storage facility swap orders for the approved parties redeeming the $U Token for physical settlement, facilitated by Madison.

Key Points: 
  • In support of the token redemption protocol, Madison may execute uranium spot market purchases; build an in-house uranium inventory; purchase futures contracts; and/or purchase storage facility swap orders for the approved parties redeeming the $U Token for physical settlement, facilitated by Madison.
  • In addition, Madison announces that in early 2024, SRK Consulting (UK) Limited (“SRK”) will deliver an NI 43-101-compliant technical report on the resource at Exclusive Prospecting Licence 8531 (“EPL-8531”).
  • “Madison is focused on the development of its uranium assets in light of the robust uranium market fundamentals.
  • The demand for sustainable energy solutions is escalating, positioning uranium as a key resource in the global energy market,” said Duane Parnham, Executive Chairman and CEO of Madison Metals.

Stride, Inc. Wins Prestigious Chemistry Education Prize for Work in Minecraft from the Royal Society of Chemistry

Retrieved on: 
金曜日, 12月 1, 2023
Primary, Secondary, Education, Consumer, Teens, Other Science, Other Education, Science, Royal Society, Chemistry, Royal, Student, Stride, Inc., Nobel Prize, Stride, Management, Minecraft

Stride, Inc. has won the prize for the development of Periodic Rescue, a chemistry game in Minecraft, that has taught basic chemistry to over 10,000 students.

Key Points: 
  • Stride, Inc. has won the prize for the development of Periodic Rescue, a chemistry game in Minecraft, that has taught basic chemistry to over 10,000 students.
  • Stride, Inc. also receives a team trophy, a custom video, a certificate and a token of recognition for each team member.
  • The Horizon Prize serves as a valuable resource, inspiring fresh ideas for your own classrooms and programs, all while contributing to the advancement of chemistry education.
  • From fundamental chemistry to cutting-edge innovations, the work that chemical scientists do has an important role to play in building our future.

Instinctif Partners Launches MENA Public Policy Advisory to Help Organizations Navigate a Changing World

Retrieved on: 
木曜日, 11月 30, 2023
FII, Royal Society, Partnership, Public policy, Partner (business rank), Risk management, Future Investment Initiative Institute, University, COP28, Foreign Service, Commerce, Communication, Pathway to Adventure Council, RSA, Royal Society of Arts, Intelligence, Teneo, AHK, WEF, GCC, World Economic Forum, Government, University of Chicago, Policy, Management, MENA

DUBAI, UAE, Nov. 30, 2023 /PRNewswire/ -- Instinctif Partners, a leading EMEA communications consultancy, is expanding its internationally-renowned Public Policy offering to the MENA region with the launch of a new practice. Integrating Public Policy advisory into its portfolio of services reflects both double-digit, year-on-year growth and fast-changing regional dynamics. From COP28 and the energy transition to renewed competition among GCC states and heightened geopolitical tensions, the MENA region continues to evolve, and clients across sectors are seeking a trusted partner to help them navigate this landscape.

Key Points: 
  • Alexander M. Wegner joins Instinctif Partners as Partner, Head of Public Policy, MENA, bringing with him 15 years' experience living and working across Doha, Dubai, and Riyadh.
  • The addition of Public Policy to our advisory services will further strengthen our capabilities and create value for our clients," said Samantha Bartel, MENA CEO and Managing Partner at Instinctif Partners.
  • "It's a pleasure to join Instinctif Partners to build, scale, and lead the Public Policy practice in MENA."
  • "It's an important and strategic step for Instinctif Partners to roll out the longstanding and thriving Public Policy practice in Africa and Europe across the booming MENA region," said Ed Amory, CEO of Instinctif Partners.

Instinctif Partners Launches MENA Public Policy Advisory to Help Organizations Navigate a Changing World

Retrieved on: 
木曜日, 11月 30, 2023
FII, Royal Society, Partnership, Public policy, Partner (business rank), Risk management, Future Investment Initiative Institute, University, COP28, Foreign Service, Commerce, Communication, Pathway to Adventure Council, RSA, Royal Society of Arts, Intelligence, Teneo, AHK, WEF, GCC, World Economic Forum, Government, University of Chicago, Policy, Management, MENA

DUBAI, UAE, Nov. 30, 2023 /PRNewswire/ -- Instinctif Partners, a leading EMEA communications consultancy, is expanding its internationally-renowned Public Policy offering to the MENA region with the launch of a new practice. Integrating Public Policy advisory into its portfolio of services reflects both double-digit, year-on-year growth and fast-changing regional dynamics. From COP28 and the energy transition to renewed competition among GCC states and heightened geopolitical tensions, the MENA region continues to evolve, and clients across sectors are seeking a trusted partner to help them navigate this landscape.

Key Points: 
  • Alexander M. Wegner joins Instinctif Partners as Partner, Head of Public Policy, MENA, bringing with him 15 years' experience living and working across Doha, Dubai, and Riyadh.
  • The addition of Public Policy to our advisory services will further strengthen our capabilities and create value for our clients," said Samantha Bartel, MENA CEO and Managing Partner at Instinctif Partners.
  • "It's a pleasure to join Instinctif Partners to build, scale, and lead the Public Policy practice in MENA."
  • "It's an important and strategic step for Instinctif Partners to roll out the longstanding and thriving Public Policy practice in Africa and Europe across the booming MENA region," said Ed Amory, CEO of Instinctif Partners.

Cytonus expands its Scientific Advisory Board with Oncolytic Virus expert John C. Bell, PhD

Retrieved on: 
木曜日, 11月 16, 2023
Royal Society, ISCB Senior Scientist Award, Research, Therapy, Potyvirus, Ottawa Hospital Research Institute, Immunology, McGill University, Vaccine, Royal, Bell, Science, University, Cancer, Virus, Outline of health sciences, McMaster University, Doctor of Philosophy, Microbiology, Medical Research Council, University of Ottawa, Pharmaceutical industry, Management, Medicine, Biochemistry, MD

SAN DIEGO, Nov. 16, 2023 /PRNewswire-PRWeb/ -- Cytonus Therapeutics, Inc., announced today that the company has expanded its Scientific Board of Advisors with the appointment of University of Ottawa Professor and pioneering researcher in the field of oncolytic viruses John C. Bell, PhD.

Key Points: 
  • Board Expansion for Cytonus Therapeutics, Inc.
    SAN DIEGO, Nov. 16, 2023 /PRNewswire-PRWeb/ -- Cytonus Therapeutics, Inc., announced today that the company has expanded its Scientific Board of Advisors with the appointment of University of Ottawa Professor and pioneering researcher in the field of oncolytic viruses John C. Bell, PhD.
  • "It is a great privilege for Cytonus to be joined by Professor Bell, who is an international leader in the field of modern viral immunotherapeutics."
  • commented Cytonus' cofounder and Chief Scientific Innovator, Richard Klemke, PhD.
  • Cytonus' Scientific Advisory Board is comprised of accomplished business leaders, distinguished research scientists, and key opinion leaders from prestigious academic institutions, immune-oncology centers, cell therapy centers, and private industry.

Nobel Laureate Hartmut Michel Joins Verseon's Scientific Advisory Board

Retrieved on: 
木曜日, 11月 9, 2023
Royal Society, University of Frankfurt Institute for Social Research, Nobel Prize in Chemistry, Max Planck Institute of Biophysics, Foreign, Verseon, Research, German Academy of Sciences at Berlin, German National Academy of Sciences Leopoldina, American Physical Society, Biophysics, Science, University, Max Planck Society, Nobel Prize, Leibniz Prize, Cancer, Tuberculosis, Vaccine, Chemistry

FREMONT, Calif., Nov. 9, 2023 /PRNewswire/ -- Verseon is pleased to announce that Dr. Hartmut Michel, winner of the 1988 Nobel Prize in Chemistry, has joined the company's scientific advisory board. Dr. Michel's work in X-ray crystallography established methodologies for crystallizing cellular membrane proteins and elucidating their structures.

Key Points: 
  • FREMONT, Calif., Nov. 9, 2023 /PRNewswire/ -- Verseon is pleased to announce that Dr. Hartmut Michel, winner of the 1988 Nobel Prize in Chemistry, has joined the company's scientific advisory board.
  • Dr. Michel is a recipient of the Biophysics Prize of the American Physical Society and is one of the original eleven recipients of the Gottfried Wilhelm Leibniz Prize , the highest honor awarded in German scientific research.
  • Verseon's team is excited to have Dr. Michel join the company's scientific advisory board.
  • We are honored to have him on our advisory board."

Nobel Laureate Hartmut Michel Joins Verseon's Scientific Advisory Board

Retrieved on: 
水曜日, 11月 8, 2023
Royal Society, University of Frankfurt Institute for Social Research, Nobel Prize in Chemistry, Royal Netherlands Academy of Arts and Sciences, Foreign, Verseon, Research, German Academy of Sciences at Berlin, German National Academy of Sciences Leopoldina, American Physical Society, Biophysics, Science, University, Nobel Prize, Leibniz Prize, Cancer, Tuberculosis, Vaccine, Chemistry

FREMONT, Calif., Nov. 8, 2023 /PRNewswire/ -- Verseon is pleased to announce that Dr. Hartmut Michel, winner of the 1988 Nobel Prize in Chemistry, has joined the company's scientific advisory board. Dr. Michel's work in X-ray crystallography established improved methodologies for crystallizing cellular membrane proteins and elucidating their structures.

Key Points: 
  • FREMONT, Calif., Nov. 8, 2023 /PRNewswire/ -- Verseon is pleased to announce that Dr. Hartmut Michel, winner of the 1988 Nobel Prize in Chemistry, has joined the company's scientific advisory board.
  • Among the many awards and prizes Dr. Michel has received are the Biophysics Prize of the American Physical Society and the Gottfried Wilhelm Leibniz Prize , the highest honor awarded in German scientific research.
  • Verseon's team is excited to have Dr. Michel join the company's scientific advisory board.
  • We are honored to have him on our advisory board."

Giga Metals Engages The Armchair Trader

Retrieved on: 
水曜日, 11月 1, 2023
Armchair, CDN, OTCQX, Royal Society of Chemistry, News, Royal Society, FSE, Furniture

VANCOUVER, British Columbia, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Mark Jarvis, CEO of Giga Metals Corp. (TSX.V: GIGA, OTCQX: GIGGF, FSE: BRR2) announced today that the Company has entered into a corporate awareness agreement with The Armchair Trader, headquartered in London.

Key Points: 
  • VANCOUVER, British Columbia, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Mark Jarvis, CEO of Giga Metals Corp. (TSX.V: GIGA, OTCQX: GIGGF, FSE: BRR2) announced today that the Company has entered into a corporate awareness agreement with The Armchair Trader, headquartered in London.
  • The Armchair Trader will provide advertising to increase awareness of the issuer through editorial content, interviews, events, podcasts and news coverage.
  • The Armchair Trader does not provide Investor Relations or Market Making services.
  • The Armchair Trader currently holds no securities in Giga Metals.